Published in Arch Int Pharmacodyn Ther on May 10, 1989
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan). Eur J Pharmacol (1967) 2.73
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol (1971) 2.15
Ca2+ triggers massive exocytosis in Chinese hamster ovary cells. EMBO J (1996) 1.80
Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneimittelforschung (1973) 1.71
A universal spine tester for in vitro experiments with muscle force simulation. Eur Spine J (1994) 1.65
Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth (2000) 1.58
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. Eur J Pharmacol (1968) 1.56
[Pharmacologic study of fenfluramine and its optical isomers]. Arch Int Pharmacodyn Ther (1966) 1.55
Contig assembly of bacterial artificial chromosome clones through multiplexed fluorescence-labeled fingerprinting. Genomics (1999) 1.48
DNA complexes obtained with the integron integrase IntI1 at the attI1 site. Nucleic Acids Res (1998) 1.46
Retroperitoneal lymphangiectasia associated with bilateral renal vein thrombosis. Nephrol Dial Transplant (1997) 1.45
Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia. J Hypertens (2000) 1.39
A technique for recording sympathetic nerve activity in unanaesthetized dogs. Neuropharmacology (1974) 1.38
Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation (2000) 1.37
Health care expenditure in the last months of life. J Health Econ (2000) 1.35
Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest (1994) 1.35
Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg (1985) 1.32
Translation in vitro of rat brain messenger RNA coding for tubulin and actin. Proc Natl Acad Sci U S A (1975) 1.31
Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol (1971) 1.26
The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinol (1997) 1.23
Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther (1969) 1.22
Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem (1997) 1.21
Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci U S A (1996) 1.19
Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol (1977) 1.16
[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)]. Dtsch Med Wochenschr (1969) 1.15
The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract (1992) 1.15
Antinociceptive effects of some alpha-sympathomimetic agents. Neuropharmacology (1974) 1.13
Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang (1991) 1.11
Measurement of spin-transfer observables in p p-->Lambda Lambda at 1.637 GeV/c. Phys Rev Lett (2002) 1.09
Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. J Cardiovasc Pharmacol (1985) 1.08
Factors affecting human islet of Langerhans isolation yields. Transplant Proc (2002) 1.06
The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract (1990) 1.06
Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabetes Care (1997) 1.05
In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc Natl Acad Sci U S A (2000) 1.05
Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem (2001) 1.04
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system. Eur J Pharmacol (1968) 1.03
Decrease in levels and rates of synthesis of tubulin and actin in developing rat brain. Brain Res (1977) 1.01
Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol (1989) 1.01
Analysis of injuries in long-distance triathletes. Int J Sports Med (2003) 1.00
Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur J Pharmacol (1969) 0.99
A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Eur J Pharmacol (1973) 0.99
Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. Mech Dev (1997) 0.99
[Actions of diazoxide on the cardiovascular system, on the metabolism of the myocardium and on sympathetic discharges]. Arch Int Pharmacodyn Ther (1968) 0.98
Effect of clonidine on sleep patterns in man. Eur J Clin Pharmacol (1977) 0.98
Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. J Pharmacol (1986) 0.97
Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol (1991) 0.97
Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Eur J Pharmacol (1974) 0.97
Isolation and expression of a cDNA encoding the precursor for a novel member (ACADSB) of the acyl-CoA dehydrogenase gene family. Genomics (1994) 0.96
International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.96
Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. Eur J Pharmacol (1980) 0.95
Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate. Circ Res (1976) 0.94
Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94
Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine. Arch Int Pharmacodyn Ther (1981) 0.93
Sports injuries: population based representative data on incidence, diagnosis, sequelae, and high risk groups. Br J Sports Med (2006) 0.93
Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency. Eur J Clin Invest (2001) 0.93
[Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome]. Rev Neurol (Paris) (2009) 0.93
Ultrasound parametric imaging of the calcaneus: in vivo results with a new device. Calcif Tissue Int (1996) 0.92
Indication for central vagal endorphinergic control of heart rate in dogs. Eur J Pharmacol (1981) 0.92
1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res (1997) 0.91
Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant (1997) 0.91
Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs. Clin Exp Pharmacol Physiol (1977) 0.90
Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density. Endocrinology (2009) 0.90
Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and alpha-adrenergic blocking drugs. Eur J Pharmacol (1970) 0.90
Interactions between the autonomic nervous system and the cardiovascular effects of ouabain in guinea-pigs. Eur J Pharmacol (1982) 0.90
[Neutrophilic dermatosis of the hands. A localized subset of Sweet's syndrome: 3 cases]. Ann Dermatol Venereol (2005) 0.90
[Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey]. Orthopade (2005) 0.89
Pharmacokinetics of gentamicin after i.v. infusion or iv bolus. J Antimicrob Chemother (1987) 0.89
Specific affinity labelling of tubulin with bromocolchicine. J Mol Biol (1976) 0.89
Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs. Neuropharmacology (1972) 0.88
New evidence for an -andrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine. Eur J Pharmacol (1972) 0.88
Image registration and analysis for quantitative myocardial perfusion: application to dynamic circular cardiac CT. Phys Med Biol (2011) 0.88
Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet (1996) 0.87
Central and peripheral effects of 2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazin (Bayer 1470) on the sympathetic system. Eur J Pharmacol (1970) 0.86
Characterization of a 72 S mitochondrial ribosome from Saccharomyces cerevisiae. Eur J Biochem (1970) 0.86
Incidence and course of icteric and anicteric transfusion hepatitis. Ger Med Mon (1966) 0.86
A cell strain system for small homogeneous strain applications. Biomed Tech (Berl) (1997) 0.86
New mechanism of antiarrhythmic drug action: increasing L-type calcium current prevents reentrant ventricular tachycardia in the infarcted canine heart. Circulation (2000) 0.86
Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. Eur J Pharmacol (1991) 0.86
Percutaneous renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys. Nephrol Dial Transplant (1994) 0.86
Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. Eur J Pharmacol (1977) 0.86
The human peroxisomal multifunctional protein involved in bile acid synthesis: activity measurement, deficiency in Zellweger syndrome and chromosome mapping. Biochim Biophys Acta (1997) 0.86
Destruction of the nucleus tractus solitarii in the dog: comparison with sinoaortic denervation. Am J Physiol (1979) 0.86
[Use of a job-exposure matrix for the screening of occupational exposure to asbestos]. Rev Epidemiol Sante Publique (2004) 0.85
[Familial malignant melanoma and atypical disseminated moles (BK-mole syndrome)]. Hautarzt (1980) 0.85
Effects of some alpha-adrenoceptor agonists and antagonists on the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.85
[Effect of sympathomimetics on the vasomotor centers]. Arch Int Pharmacodyn Ther (1971) 0.85
Dynamic changes in electrogram morphology at functional lines of block in reentrant circuits during ventricular tachycardia in the infarcted canine heart: a new method to localize reentrant circuits from electrogram features using adaptive template matching. J Cardiovasc Electrophysiol (1999) 0.85
[Changes in the hypertensive effects of angiotensin by adrenergic and anti-adrenergic agents]. Arch Int Pharmacodyn Ther (1968) 0.85
Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation. Mucosal Immunol (2012) 0.85